| 血清CA125、CA19-9、CEA的检测在大肠癌诊断及治疗中的意义 |
| |
| 引用本文： | 魏宜胜,常家聪,王少波.血清CA125、CA19-9、CEA的检测在大肠癌诊断及治疗中的意义[J].肿瘤防治研究,2006,33(8):585-587. |
| |
| 作者姓名： | 魏宜胜 常家聪 王少波 |
| |
| 作者单位： | 安徽医科大学第一附属医院普外科; 安徽省淮南市第五人民医院普外科; |
| |
| 摘 要： | 目的探讨血清CA125、CA199、CEA的检测在大肠癌诊断及治疗中的价值。方法82例大肠癌病人均于2004年6月～2005年6月收治并手术,同时选取41例正常人做为对照组。以蛋白芯片法测定两组血清中CA125、CA199、CEA含量。结果三项指标定量检测大肠癌组明显高于对照组。其阳性率与部位、大体类型、组织类型无明显相关。三项指标阳性率Duke'sC+D期明显高于Duke'sA+B期。CA125、CA199、CEA三项指标敏感度分别为34.1%、34.1%、30.5%,特异度均为97.6%,三项联检敏感度为58.5%,特异度为92.7%,而在Duke'sC+D期,三项联检敏感度为86.8%,特异度为92.7%。结论血清CA125、CA199、CEA的检测对于大肠癌的诊断价值较低,但三项联检在Duke'sC、D期大肠癌病人诊断价值较高,有助于判断大肠癌病理分期并指导手术范围。
|
| 关 键 词： | CA125 CA19-9 CEA 大肠癌 |
| 文章编号： | 1000-8578（2006）08-0585-03 |
| 收稿时间： | 2005-08-29 |
| 修稿时间： | 2005-08-292005-10-18 |
Diagnostic and Therapeutic Value of Serum CA125, CA19-9 and CEA in Colorectal Carcinoma |
| |
| WEI Yi-sheng,CHANG Jia-cong,WANG Shao-bo.Diagnostic and Therapeutic Value of Serum CA125, CA19-9 and CEA in Colorectal Carcinoma[J].Cancer Research on Prevention and Treatment,2006,33(8):585-587. |
| |
| Authors: | WEI Yi-sheng CHANG Jia-cong WANG Shao-bo |
| |
| Institution: | 1.Department of Gastrointestinal Surgery; The First Affiliated Hospital; Anhui Medical University; Hefei 230022; China; 2.Department of General Surgery; The Fifth People; s Hospital of Huainan; |
| |
| Abstract: | Objective To evaluate the diagnostic and therapeutic value of serum CA125,CA19-9 and CEA in colorectal carcinoma.Methods A total of 82 patients with colorectal carcinoma had been treated surgically between June 2004 and June 2005.The control group included 41 healthy adults.The serum CA125,CA19-9 and CEA are determined by protein chip.Results The levels of serum CA125,CA19-9 were higher in the colorectal cancer group than in the control group.The positive rates of serum CA125,CA19-9 and CEA were not associa... |
| |
| Keywords: | CA125 CA19-9 CEA |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《肿瘤防治研究》浏览原始摘要信息 |
| 点击此处可从《肿瘤防治研究》下载免费的PDF全文 |
